ResearcherKarolinska University HospitalNo recent work listed
Qingda Meng
Matched on OpenAlex author ID A5112124637. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2014: 2 papers · 2015: 1 paper · 2016: 1 paper · 2017: none · 2018: 3 papers · 2019: 1 paper
Papers 8
- Neoepitope targets of tumour-infiltrating lymphocytes from patients with pancreatic cancer. Co-author DOI 10.1038/s41416-018-0262-z↗
- CMV and EBV targets recognized by tumor-infiltrating B lymphocytes in pancreatic cancer and brain tumors. Co-author DOI 10.1038/s41598-018-34710-2↗
- Prediction of improved survival in patients with pancreatic cancer via IL-21 enhanced detection of mesothelin epitope-reactive T-cell responses. Co-author DOI 10.18632/oncotarget.25121↗
- KRAS RENAISSANCE(S) in Tumor Infiltrating B Cells in Pancreatic Cancer. Co-author DOI 10.3389/fonc.2018.00384↗
- Expansion of Tumor-reactive T Cells From Patients With Pancreatic Cancer. Co-author DOI 10.1097/cji.0000000000000111↗
- Enhanced tumor-infiltrating lymphocytes (eTIL) for cellular therapy of patients with pancreatic cancer or glioblastoma Co-author DOI 10.1186/2051-1426-3-s2-p35↗
- A fast assay to gauge for TAA-reactive T cells in PBMCS from patients with pancreatic cancer First author DOI 10.1186/2051-1426-2-s3-p25↗
- Generation of tumor-infiltrating lymphocytes from pancreatic cancer lesions for cellular therapy Co-author DOI 10.1186/2051-1426-2-s3-p26↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Markus J. Maeurer · 8 shared papers, 2014–2019 · strength 0.57
- Paper KRAS RENAISSANCE(S) in Tumor Infiltrating B Cells in Pancreatic Cancer. DOI 10.3389/fonc.2018.00384↗
- Paper CMV and EBV targets recognized by tumor-infiltrating B lymphocytes in pancreatic cancer and brain tumors. DOI 10.1038/s41598-018-34710-2↗
- Paper Neoepitope targets of tumour-infiltrating lymphocytes from patients with pancreatic cancer. DOI 10.1038/s41416-018-0262-z↗
- Ernest Dodoo · 7 shared papers, 2014–2019 · strength 0.45
- Paper CMV and EBV targets recognized by tumor-infiltrating B lymphocytes in pancreatic cancer and brain tumors. DOI 10.1038/s41598-018-34710-2↗
- Paper Neoepitope targets of tumour-infiltrating lymphocytes from patients with pancreatic cancer. DOI 10.1038/s41416-018-0262-z↗
- Paper Prediction of improved survival in patients with pancreatic cancer via IL-21 enhanced detection of mesothelin epitope-r… DOI 10.18632/oncotarget.25121↗
- Elena B. Rangelova · 6 shared papers, 2014–2019 · strength 0.35
- Paper Neoepitope targets of tumour-infiltrating lymphocytes from patients with pancreatic cancer. DOI 10.1038/s41416-018-0262-z↗
- Paper Prediction of improved survival in patients with pancreatic cancer via IL-21 enhanced detection of mesothelin epitope-r… DOI 10.18632/oncotarget.25121↗
- Paper Expansion of Tumor-reactive T Cells From Patients With Pancreatic Cancer. DOI 10.1097/cji.0000000000000111↗
- Marco Del Chiaro · 3 shared papers, 2016–2019 · strength 0.22
- Paper Neoepitope targets of tumour-infiltrating lymphocytes from patients with pancreatic cancer. DOI 10.1038/s41416-018-0262-z↗
- Paper Prediction of improved survival in patients with pancreatic cancer via IL-21 enhanced detection of mesothelin epitope-r… DOI 10.18632/oncotarget.25121↗
- Paper Expansion of Tumor-reactive T Cells From Patients With Pancreatic Cancer. DOI 10.1097/cji.0000000000000111↗
- Caroline Sophie Verbeke · 4 shared papers, 2014–2016 · strength 0.18
- Paper Expansion of Tumor-reactive T Cells From Patients With Pancreatic Cancer. DOI 10.1097/cji.0000000000000111↗
- Paper Enhanced tumor-infiltrating lymphocytes (eTIL) for cellular therapy of patients with pancreatic cancer or glioblastoma DOI 10.1186/2051-1426-3-s2-p35↗
- Paper A fast assay to gauge for TAA-reactive T cells in PBMCS from patients with pancreatic cancer DOI 10.1186/2051-1426-2-s3-p25↗
- Matthias J. Löhr · 3 shared papers, 2015–2018 · strength 0.17
- Paper Prediction of improved survival in patients with pancreatic cancer via IL-21 enhanced detection of mesothelin epitope-r… DOI 10.18632/oncotarget.25121↗
- Paper Expansion of Tumor-reactive T Cells From Patients With Pancreatic Cancer. DOI 10.1097/cji.0000000000000111↗
- Paper Enhanced tumor-infiltrating lymphocytes (eTIL) for cellular therapy of patients with pancreatic cancer or glioblastoma DOI 10.1186/2051-1426-3-s2-p35↗
- Carlos Fernández Moro · 1 shared paper, 2019 · strength 0.09
- Elke Jäger · 1 shared paper, 2019 · strength 0.09
- Ann Morgell · 1 shared paper, 2018 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.